Hemostasis Diagnostics Market
Hemostasis Diagnostics Market Analysis By Product (Laboratory Systems, Consumables, Point-of-Care Testing Systems), By Test (Prothrombin Test Time (PT), Activated Partial Thromboplastin Time (APTT), Fibrinogen Degradation Products (FDP)), By End User, By Region - Global Insights 2031
Analysis of Hemostasis Diagnostics market covering 30 + countries including analysis of US, Canada, UK, Germany, France, Nordics, GCC countries, Japan, Korea and many more
Market Outlook for Hemostasis Diagnostics
As per the latest industry analysis on hemostasis diagnostics by Fact.MR, the global market was valued at around US$ 2 Bn in 2020, and is expected to accelerate at a CAGR of 7% to double in valuation and top US$ 4 Bn by 2031. Demand for point-of-care testing systems to rise at a CAGR of 5% across the assessment period of 2021 to 2031.
Key Points Covered in Hemostasis Diagnostics Industry Survey:
- Market Estimates and Forecasts (2016-2031)
- Key Drivers and Restraints Shaping Market Growth
- Segment-wise, Country-wise, and Region-wise Analysis
- Competition Mapping and Benchmarking
- Brand Share and Market Share Analysis
- Key Product Innovations and Regulatory Climate
- COVID-19 Impact on Demand for Hemostasis Diagnostics and How to Navigate
- Recommendation on Key Winning Strategies
Know thy Competitors
Competitive landscape highlights only certain players
Complete list available upon request
Hemostasis Diagnostics Demand Analysis from 2016-2020 Vs Future Market Outlook for 2021 to 2031
As per Fact.MR - a market research and competitive intelligence provider, the global market for hemostasis diagnostics was valued at US$ 2 Bn in 2020, and is anticipated to expand at a CAGR of around 7% to top US$ 4 Bn by 2031.
Hemostasis diagnostics help identify hemostatic defects that cause excessive bleeding. Rising incidence of blood clotting in patients particularly who are more prone to losing excess blood from the body during surgeries is a major factor contributing to market growth.
Increasing awareness about hemostasis conditions is expected to improve diagnostic rate and preventive care management, which is predicted to substantially increase testing volumes. Technological advancements have led to the introduction of many novel diagnostic systems and tests, such as introduction of automated blood coagulation analyzers, providing significant growth opportunities for market participants.
How are Technological Advancements Creating Ample Opportunities for Hemostasis Diagnostic Product Manufacturers?
Technology is evolving rapidly. In recent years, blood coagulation monitoring has become crucial to diagnosing the causes of hemorrhages, developing anticoagulant drugs, assessing bleeding risk in extensive surgery procedures and dialysis, and investigating the efficacy of hemostatic therapies.
Hemostasis diagnostics devices have come a long way from quantifying optical density of clots in a cuvette to detection of clotting factors.
Platelet function analyzers, functional assays of particular coagulation proteins, molecular typing immunologic assays, chromogenic assays, and flow cytometry and are examples of these techniques. Advances in technology have resulted in greater capability, productivity, sensitivity, specificity, and ultimately improvement in the clinical care of patients.
More Insights, Lesser Cost (-50% off)
Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR
Will Rise in Coagulation Disorders Fuel Demand for Hemostasis Diagnostics?
Coagulation disorders are issues with the body’s capacity to clot blood. These conditions may result in hemorrhage or thrombosis. Coagulatory disorders can be caused by a variety of factors. These conditions can be developed or inherited. Platelet dysfunction, von Willebrand disease, and hemophilia are some of the most common coagulation disorders that can trigger bleeding.
In addition, disseminated intravascular coagulation, deficiency of Vitamin K, and other clotting defects are causes of coagulation disorders that can lead to bleeding. Rising cases are likely to work in favor of the global hemostasis diagnostics market in near future.
Which Region is a Lucrative Market for Hemostasis Diagnostic Product Manufacturers?
North America accounts for around 50% of the global market share for hemostasis diagnostics. Dominance of this region is mainly attributed to rising healthcare infrastructure, high adoption of advanced automated analyzers, and presence of a large patient pool.
In addition, increasing prevalence of numerous blood clot disorders is aggressively propelling demand for hemostasis diagnosis. According to the National Hemophilia Foundation, in 2019, approximately 20,000 Americans were living with hemophilia, thereby positively impacting market growth is North America.
Furthermore, technological advancements have increased access to healthcare services, and entry of new manufacturers are likely to fuel market expansion in the region over the years to come.
Country-wise Analysis
What is the Demand Outlook for Hemostasis Diagnostics in the U.S.?
The market in the U.S was valued at around US$ 620 Mn in 2020. Rise in prevalence of cardiovascular diseases, deep vein thrombosis, and genetic & acquired blood clotting disorders, and advanced healthcare facilities & infrastructure are expected to promote growth of market across the region over the forecast period.
Why is China Flourishing in the Global Market for Hemostasis Diagnostics?
China is forecast to reach a projected market size of around US$ 800 Mn by 2031. Increased prevalence of various hemostasis disorders, presence of regional and international market players, and massive investments in R&D across the country are expected to notably contribute toward the country’s market.
China spends 6% of its GDP on healthcare, according to estimates, and its medical equipment market has grown by double digits over the previous three decades.
Improving healthcare infrastructure, increasing focus of emerging and leading market players on developing markets, rise in number of hospitals, increase in incidence of cardiovascular diseases, and growing adoption of hemostasis diagnostics as part of the treatment of diseases are some of the key factors that have driven demand for hemostasis diagnostics in China.
Don't Need a Global Report?
save 40%! on Country & Region specific reports
Category-wise Insights
Why are Point-of-Care Testing Systems Gaining Immense Popularity?
Sales of point-of-care testing systems are forecast to reach a market value of US$ 400 Mn by 2031. Continuous developments in R&D activities to miniaturize molecular and professional diagnostic tests is anticipated to drive demand for these systems.
In addition, improvements in lab automation techniques coupled with introduction of cost-effective and high-quality medical solutions are set to propel segment growth. Patients and clinicians are more inclined towards the usage of POC diagnostic tests with increasing levels of patient awareness about POC processes.
Also, minimally skilled professionals efficiently use POC devices for diagnosis, which serves as one of the segmental drivers.
Several private entities such as the California Institute of Technology, Dartmouth College, and global organizations are involved in POC development programs.
For instance, in August 2018, the American Association for Clinical Chemistry released a certification program for POC testing professionals to improve their diagnostic testing outside clinical laboratories. As such, the segment is likely to witness lucrative growth over the forecast period.
How is Popularity of the D Dimer Test Stimulating Market Growth?
The d dimer test is most often used to find out whether a patient has a blood clotting disorder. The utility of d dimer measurement has been evaluated in several clinical situations including the exclusion of venous thromboembolism (VTE), prediction of future risk of VTE, and the diagnosis and monitoring of disseminated intravascular coagulation (DIC).
Why is Demand for Hemostasis Diagnostics High across Hospitals?
Owing to increasing investments by both, emerging and emerged economies in the healthcare sector, there has been a rise in the construction of hospitals and expansion of established ones. The segment is driven by rise in hospitalizations due to cardiology disorders and increase in the number of hospitals across regions.
How Has COVID-19 Affected Demand for Hemostasis Diagnostics?
Implementation of lockdowns and transport bans due to the COVID-19 pandemic has caused disruptions in all sectors, including the demand for hemostasis diagnostics. Lack of raw materials has caused a slowdown in the production of medical equipment.
Medical equipment needs to go through a series of pre- and post-market clinical investigations before receiving market authorization certificates. Medical and healthcare departments are operating at full capacity to treat patients as the COVID-19 pandemic spreads. This has led to advancements in technologies and products being used in healthcare.
The year 2021 is projected to be better, with the market regaining its original traction by 2022.
Competitive Landscape
Major players with a prominent share in the market are focusing on expanding their customer base.
- In 2017, Werfen and its subsidiary Instrumentation Laboratory Company acquired Accriva Diagnostics to expand leadership in point-of-care testing.
- In 2018, Sysmex Corporation launched its next-generation analyzers in the hemostasis field - the Automated Blood Coagulation Analyzers CN-6000 and CN-3000.
- In 2019, Horiba Medical, launched its new parameter, Yumizen D-Dimer, for its Yumizen G Hemostasis range of instruments to diagnose deep vein thrombosis and pulmonary embolism.
Hemostasis Diagnostics Market Report Scope
|
Attribute |
Details |
|
Forecast Period |
2021-2031 |
|
Historical Data Available for |
2016-2020 |
| Key Regions Covered |
|
|
Key Market Segments Covered |
|
| Key Market Segments Covered |
|
|
Key Companies Profiled
|
|
| Pricing |
Available upon Request |
Market Categorization as Per Hemostasis Diagnostics Industry Research
-
Product
- Laboratory Systems
- Consumables
- Point-of-Care Testing Systems
-
Test
- Prothrombin Test Time (PT)
- Activated Partial Thromboplastin Time (APTT)
- Fibrinogen Degradation Products (FDP)
- Activated Clotting Time
- Platelet Aggregation Test
- D Dimer
-
End User
- Hemostasis Diagnostics at Hospital and Clinics
- Hemostasis Diagnostics at Research Institutes
- Hemostasis Diagnostics at Independent Diagnostic Laboratories
Table of Content
1. Global Hemostasis Diagnostics Market - Executive Summary 1.1. Global Market Overview 1.2. Demand Side Trends 1.3. Supply Side Trends 1.4. Fact.MR Analysis and recommendation 2. Global Hemostasis Diagnostics Market Overview 2.1. Market Coverage / Taxonomy 2.2. Market Introduction and Definition 3. Market Risks and Trends Assessment 3.1. Risk Assessment 3.1.1. COVID-19 Crisis and Impact on Hemostasis Diagnostics 3.1.2. COVID-19 Crisis and Impact on Hemostasis Diagnostics Prices 3.1.3. COVID-19 Impact Benchmark with Previous Crisis 3.1.3.1. Change in Hemostasis Diagnostics Demand 3.1.3.2. Before and After COVID-19 Crisis (Projected) 3.1.3.3. Before and After Sub-prime Crisis – 2008 (Actual) 3.1.3.4. Change in Demand post Recovery Period (After Each Crisis) 3.1.4. Impact on Market and Value (US$ Mn) 3.1.4.1. Likely Loss of Value in 2020 3.1.4.2. Mid-term and Long Term Forecast 3.1.4.3. Quarter by Quarter Demand and Recovery Assessment 3.1.5. Anticipated Demand and Value Recovery Curve 3.1.5.1. Likelihood of U-Shape Recovery 3.1.5.2. Likelihood of L-Shape Recovery 3.1.6. Recovery Period Assessment by Key Countries 3.1.7. Recovery Assessment by Key Market Segments 3.1.8. Action Points and Recommendation for Suppliers 3.1.9. Impact on Trade Balance 3.2. Key Trends Impacting the Market 3.3. Formulation and Test Development Trends 4. Market Background and foundation Data Points 4.1. Manufacturing Sector Reached here in Leaps and Bounds 4.2. Need of the Hour for Industries 4.3. Manufacturing Sector at Fore-Front of Technology Adoption 4.4. Industry Wise Industry 4.0 4.5. Hemostasis Diagnostics – Strategic Priorities 4.6. Test life Cycle Stage 4.7. Importance of Technology 4.8. Hemostasis Diagnostics: Hype Cycle 4.9. 5 Reasons to Implement Hemostasis Diagnostics 4.10. Hemostasis Diagnostics Test 4.11. A Concluding Gap in Industrial Digitization 4.12. 5G – Future of Communications Platform 4.13. 5G vs 4G Comparison 4.14. Use Cases of Hemostasis Diagnostics in Manufacturing 4.15. Forecast Factors: Relevance and Impact 4.16. Investment Feasibility Matrix 4.17. PESTLE Analysis 4.18. Porter’s Five Forces Analysis 4.19. Market Dynamics 4.19.1. Drivers 4.19.2. Restraints 4.19.3. Opportunity Analysis 4.19.4. Trend 5. Global Hemostasis Diagnostics Market Demand (US$ Mn) Analysis 2016-2020 and Forecast, 2021-2031 5.1. Historical Market Value (US$ Mn) Analysis, 2016-2020 5.2. Current and Future Market Value (US$ Mn) Projections, 2021-2031 5.2.1. Y-o-Y Growth Trend Analysis 5.2.2. Absolute $ Opportunity Analysis 6. Global Hemostasis Diagnostics Market Analysis 2016-2020 and Forecast 2021-2031, By Test 6.1. Introduction / Key Findings 6.2. Historical Market Value (US$ Mn) Analysis By Test, 2016-2020 6.3. Current and Future Market Value (US$ Mn) Analysis and Forecast By Test, 2021-2031 6.3.1. Prothrombin Test Time (PT) 6.3.2. Activated Partial Thromboplastin Time (APTT) 6.3.3. Fibrinogen Degradation Products (FDP) 6.3.4. Activated Clotting Time 6.3.5. Platelet Aggregation Test 6.3.6. D Dimer 6.4. Market Attractiveness Analysis By Test 7. Global Hemostasis Diagnostics Market Analysis 2016-2020 and Forecast 2021-2031, by Product 7.1. Introduction / Key Findings 7.2. Historical Market Value (US$ Mn) Analysis By Product , 2016-2020 7.3. Current and Future Market Value (US$ Mn) Analysis and Forecast By Product, 2021-2031 7.3.1. Laboratory Systems 7.3.2. Consumables 7.3.3. Point-of-Care Testing Systems 7.4. Market Attractiveness Analysis By Product 8. Global Hemostasis Diagnostics Market Analysis 2016-2020 and Forecast 2021-2031, by End User 8.1. Introduction / Key Findings 8.2. Historical Market Value (US$ Mn) Analysis By End User, 2016-2020 8.3. Current and Future Market Value (US$ Mn) Analysis and Forecast By End User, 2021-2031 8.3.1. Hospital and Clinics 8.3.2. Research Institutes 8.3.3. Independent Diagnostic Laboratories 8.4. Market Attractiveness Analysis By End User 9. Global Hemostasis Diagnostics Market Analysis 2016-2020 and Forecast 2021-2031, by Region 9.1. Introduction / Key Findings 9.2. Historical Market Value (US$ Mn) Analysis By Region, 2016-2020 9.3. Current and Future Market Value (US$ Mn) Analysis and Forecast By Region, 2021-2031 9.3.1. North America 9.3.2. Latin America 9.3.3. Europe 9.3.4. East Asia 9.3.5. South Asia & Oceania 9.3.6. Middle East and Africa (MEA) 9.4. Market Attractiveness Analysis By Region 10. North America Hemostasis Diagnostics Market Analysis 2016-2020 and Forecast 2021-2031 10.1. Introduction / Key Findings 10.2. Historical Market Value (US$ Mn) Trend Analysis By Market Taxonomy, 2016-2020 10.3. Market Value (US$ Mn) Forecast By Market Taxonomy, 2021-2031 10.3.1. By Country 10.3.1.1. U.S. 10.3.1.2. Canada 10.3.2. By Test 10.3.3. By Product 10.4. Market Attractiveness Analysis 10.4.1. By Country 10.4.2. By Test 10.4.3. By Product 11. Latin America Hemostasis Diagnostics Market Analysis 2016-2020 and Forecast 2021-2031 11.1. Introduction / Key Findings 11.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2016-2020 11.3. Current and Future Market Value (US$ Mn) Analysis and Forecast By Region, 2021-2031 11.3.1. By Country 11.3.1.1. Brazil 11.3.1.2. Mexico 11.3.1.3. Rest of Latin America 11.3.2. By Test 11.3.3. By Product 11.3.4. By End User 11.4. Market Attractiveness Analysis 11.4.1. By Country 11.4.2. By Test 11.4.3. By Product 11.4.4. By End User 12. Europe Hemostasis Diagnostics Market Analysis 2016-2020 and Forecast 2021-2031 12.1. Introduction / Key Findings 12.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2016-2020 12.3. Current and Future Market Value (US$ Mn) Analysis and Forecast By Region, 2021-2031 12.3.1. By Country 12.3.1.1. Germany 12.3.1.2. France 12.3.1.3. Italy 12.3.1.4. Spain 12.3.1.5. UK 12.3.1.6. BENELUX 12.3.1.7. Russia 12.3.1.8. Rest of Europe 12.3.2. By Test 12.3.3. By Product 12.3.4. By End User 12.4. Market Attractiveness Analysis 12.4.1. By Country 12.4.2. By Test 12.4.3. By Product 12.4.4. By End User 13. East Asia Hemostasis Diagnostics Market Analysis 2016-2020 and Forecast 2021-2031 13.1. Introduction / Key Findings 13.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2016-2020 13.3. Current and Future Market Value (US$ Mn) Analysis and Forecast By Region, 2021-2031 13.3.1. By Country 13.3.1.1. China 13.3.1.2. Japan 13.3.1.3. South Korea 13.3.2. By Test 13.3.3. By Product 13.3.4. By End User 13.4. Market Attractiveness Analysis 13.4.1. By Country 13.4.2. By Test 13.4.3. By Product 13.4.4. By End User 14. South Asia & Oceania Hemostasis Diagnostics Market Analysis 2016-2020 and Forecast 2021-2031 14.1. Introduction / Key Findings 14.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2016-2020 14.3. Current and Future Market Value (US$ Mn) Analysis and Forecast By Region, 2021-2031 14.3.1. By Country 14.3.1.1. India 14.3.1.2. Thailand 14.3.1.3. Malaysia 14.3.1.4. Singapore 14.3.1.5. Vietnam 14.3.1.6. ANZ 14.3.1.7. Rest of South Asia & Oceania 14.3.2. By Test 14.3.3. By Product 14.3.4. By End User 14.4. Market Attractiveness Analysis 14.4.1. By Country 14.4.2. By Test 14.4.3. By Product 14.4.4. By End User 15. Middle East and Africa Hemostasis Diagnostics Market Analysis 2016-2020 and Forecast 2021-2031 15.1. Introduction / Key Findings 15.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2016-2020 15.3. Current and Future Market Value (US$ Mn) Analysis and Forecast By Region, 2021-2031 15.3.1. By Country 15.3.1.1. GCC Countries 15.3.1.2. South Africa 15.3.1.3. Israel 15.3.1.4. Rest of Middle East and Africa (MEA) 15.3.2. By Test 15.3.3. By Product 15.3.4. By End User 15.4. Market Attractiveness Analysis 15.4.1. By Country 15.4.2. By Test 15.4.3. By Product 15.4.4. By End User 16. Market Structure Analysis 16.1. Market Analysis by Tier of Companies 16.2. Market Concentration 16.3. Market Share Analysis of Top Players 16.4. Market Presence Analysis 17. Competition Analysis 17.1. Competition Dashboard 17.2. Competition Benchmarking 17.3. Competition Deep Dive 17.4. Abbott Laboratories 17.4.1. Company Overview 17.4.2. Test overview 17.4.3. SWOT Analysis 17.4.4. Key Developments 17.5. HORIBA, Ltd. 17.5.1. Company Overview 17.5.2. Test overview 17.5.3. SWOT Analysis 17.5.4. Key Developments 17.6. F. Hoffmann-La Roche Ltd. 17.6.1. Company Overview 17.6.2. Test overview 17.6.3. SWOT Analysis 17.6.4. Key Developments 17.7. Nihon Kohden Corporation 17.7.1. Company Overview 17.7.2. Test overview 17.7.3. SWOT Analysis 17.7.4. Key Developments 17.8. Thermo fisher Scientific Inc. 17.8.1. Company Overview 17.8.2. Test overview 17.8.3. SWOT Analysis 17.8.4. Key Developments 17.9. Danaher Corporation 17.9.1. Company Overview 17.9.2. Test overview 17.9.3. SWOT Analysis 17.9.4. Key Developments 17.10. Sysmex Corporation 17.10.1. Company Overview 17.10.2. Test overview 17.10.3. SWOT Analysis 17.10.4. Key Developments 17.11. Siemens Healthineers 17.11.1. Company Overview 17.11.2. Test overview 17.11.3. SWOT Analysis 17.11.4. Key Developments 17.12. Alere Inc. 17.12.1. Company Overview 17.12.2. Test overview 17.12.3. SWOT Analysis 17.12.4. Key Developments 17.13. Instrumentation Laboratory 17.13.1. Company Overview 17.13.2. Test overview 17.13.3. SWOT Analysis 17.13.4. Key Developments 17.14. Grifols S.A. 17.14.1. Company Overview 17.14.2. Test overview 17.14.3. SWOT Analysis 17.14.4. Key Developments 17.15. Medtronic 17.15.1. Company Overview 17.15.2. Test overview 17.15.3. SWOT Analysis 17.15.4. Key Developments 17.16. Beckman Coulter, Inc. 17.16.1. Company Overview 17.16.2. Test overview 17.16.3. SWOT Analysis 17.16.4. Key Developments 17.17. Helena Labor 17.17.1. Company Overview 17.17.2. Test overview 17.17.3. SWOT Analysis 17.17.4. Key Developments 18. Assumptions And Acronyms Used 19. Research Methodology
Don't Need a Global Report?
save 40%! on Country & Region specific reports
List Of Table
Table 1: Global Hemostasis Diagnostics Market Value (US$ Mn) Analysis, by Test, 2016-2020
Table 2: Global Hemostasis Diagnostics Market Value (US$ Mn) Analysis, by Test, 2021-2031
Table 3: Global Hemostasis Diagnostics Market Value (US$ Mn) Opportunity Analysis, by Test, 2021-2031
Table 4: Global Hemostasis Diagnostics Market Value (US$ Mn) Analysis, by Product, 2016-2020
Table 5: Global Hemostasis Diagnostics Market Value (US$ Mn) Analysis, by Product, 2021-2031
Table 6: Global Hemostasis Diagnostics Market Value (US$ Mn) Opportunity Analysis, by Product, 2021-2031
Table 7: Global Hemostasis Diagnostics Market Value (US$ Mn) Analysis, by End User, 2016-2020
Table 8: Global Hemostasis Diagnostics Market Value (US$ Mn) Analysis, by End User, 2021-2031
Table 9: Global Hemostasis Diagnostics Market Value (US$ Mn) Opportunity Analysis, by End User, 2021-2031
Table 10: Global Hemostasis Diagnostics Market Value (US$ Mn) Analysis, by Region, 2016-2020
Table 11: Global Hemostasis Diagnostics Market Value (US$ Mn) Analysis, by Region, 2021-2031
Table 12: Global Hemostasis Diagnostics Market Value (US$ Mn) Opportunity Analysis, by Region, 2021-2031
Table 13: North America Hemostasis Diagnostics Market Value (US$ Mn) Analysis, by Country, 2016-2020
Table 14: North America Hemostasis Diagnostics Market Value (US$ Mn) Analysis, by Country, 2021-2031
Table 15: North America Hemostasis Diagnostics Market Value (US$ Mn) Opportunity Analysis, by Country, 2021-2031
Table 16: North America Hemostasis Diagnostics Market Value (US$ Mn) Analysis, by Test, 2016-2020
Table 17: North America Hemostasis Diagnostics Market Value (US$ Mn) Analysis, by Test, 2021-2031
Table 18: North America Hemostasis Diagnostics Market Value (US$ Mn) Opportunity Analysis, by Test, 2021-2031
Table 19: North America Hemostasis Diagnostics Market Value (US$ Mn) Analysis, by Product, 2016-2020
Table 20: North America Hemostasis Diagnostics Market Value (US$ Mn) Analysis, by Product, 2021-2031
Table 21: North America Hemostasis Diagnostics Market Value (US$ Mn) Opportunity Analysis, by Product, 2021-2031
Table 22: North America Hemostasis Diagnostics Market Value (US$ Mn) Analysis, by End User, 2016-2020
Table 23: North America Hemostasis Diagnostics Market Value (US$ Mn) Analysis, by End User, 2021-2031
Table 24: North America Hemostasis Diagnostics Market Value (US$ Mn) Opportunity Analysis, by End User, 2021-2031
Table 25: Latin America Hemostasis Diagnostics Market Value (US$ Mn) Analysis, by Country, 2016-2020
Table 26: Latin America Hemostasis Diagnostics Market Value (US$ Mn) Analysis, by Country, 2021-2031
Table 27: Latin America Hemostasis Diagnostics Market Value (US$ Mn) Opportunity Analysis, by Country, 2021-2031
Table 28: Latin America Hemostasis Diagnostics Market Value (US$ Mn) Analysis, by Test, 2016-2020
Table 29: Latin America Hemostasis Diagnostics Market Value (US$ Mn) Analysis, by Test, 2021-2031
Table 30: Latin America Hemostasis Diagnostics Market Value (US$ Mn) Opportunity Analysis, by Test, 2021-2031
Table 31: Latin America Hemostasis Diagnostics Market Value (US$ Mn) Analysis, by Product, 2016-2020
Table 32: Latin America Hemostasis Diagnostics Market Value (US$ Mn) Analysis, by Product, 2021-2031
Table 33: Latin America Hemostasis Diagnostics Market Value (US$ Mn) Opportunity Analysis, by Product, 2021-2031
Table 34: Latin America Hemostasis Diagnostics Market Value (US$ Mn) Analysis, by End User, 2016-2020
Table 35: Latin America Hemostasis Diagnostics Market Value (US$ Mn) Analysis, by End User, 2021-2031
Table 36: Latin America Hemostasis Diagnostics Market Value (US$ Mn) Opportunity Analysis, by End User, 2021-2031
Table 37: Europe Hemostasis Diagnostics Market Value (US$ Mn) Analysis, by Country, 2016-2020
Table 38: Europe Hemostasis Diagnostics Market Value (US$ Mn) Analysis, by Country, 2021-2031
Table 39: Europe Hemostasis Diagnostics Market Value (US$ Mn) Opportunity Analysis, by Country, 2021-2031
Table 40: Europe Hemostasis Diagnostics Market Value (US$ Mn) Analysis, by Test, 2016-2020
Table 41: Europe Hemostasis Diagnostics Market Value (US$ Mn) Analysis, by Test, 2021-2031
Table 42: Europe Hemostasis Diagnostics Market Value (US$ Mn) Opportunity Analysis, by Test, 2021-2031
Table 43: Europe Hemostasis Diagnostics Market Value (US$ Mn) Analysis, by Product, 2016-2020
Table 44: Europe Hemostasis Diagnostics Market Value (US$ Mn) Analysis, by Product, 2021-2031
Table 45: Europe Hemostasis Diagnostics Market Value (US$ Mn) Opportunity Analysis, by Product, 2021-2031
Table 46: Europe Hemostasis Diagnostics Market Value (US$ Mn) Analysis, by End User, 2016-2020
Table 47: Europe Hemostasis Diagnostics Market Value (US$ Mn) Analysis, by End User, 2021-2031
Table 48: Europe Hemostasis Diagnostics Market Value (US$ Mn) Opportunity Analysis, by End User, 2021-2031
Table 49: East Asia Hemostasis Diagnostics Market Value (US$ Mn) Analysis, by Country, 2016-2020
Table 50: East Asia Hemostasis Diagnostics Market Value (US$ Mn) Analysis, by Country, 2021-2031
Table 51: East Asia Hemostasis Diagnostics Market Value (US$ Mn) Opportunity Analysis, by Country, 2021-2031
Table 52: East Asia Hemostasis Diagnostics Market Value (US$ Mn) Analysis, by Test, 2016-2020
Table 53: East Asia Hemostasis Diagnostics Market Value (US$ Mn) Analysis, by Test, 2021-2031
Table 54: East Asia Hemostasis Diagnostics Market Value (US$ Mn) Opportunity Analysis, by Test, 2021-2031
Table 55: East Asia Hemostasis Diagnostics Market Value (US$ Mn) Analysis, by Product, 2016-2020
Table 56: East Asia Hemostasis Diagnostics Market Value (US$ Mn) Analysis, by Product, 2021-2031
Table 57: East Asia Hemostasis Diagnostics Market Value (US$ Mn) Opportunity Analysis, by Product, 2021-2031
Table 58: East Asia Hemostasis Diagnostics Market Value (US$ Mn) Analysis, by End User, 2016-2020
Table 59: East Asia Hemostasis Diagnostics Market Value (US$ Mn) Analysis, by End User, 2021-2031
Table 60: East Asia Hemostasis Diagnostics Market Value (US$ Mn) Opportunity Analysis, by End User, 2021-2031
Table 61: South Asia & Oceania Hemostasis Diagnostics Market Value (US$ Mn) Analysis, by Country, 2016-2020
Table 62: South Asia & Oceania Hemostasis Diagnostics Market Value (US$ Mn) Analysis, by Country, 2021-2031
Table 63: South Asia & Oceania Hemostasis Diagnostics Market Value (US$ Mn) Opportunity Analysis, by Country, 2021-2031
Table 64: South Asia & Oceania Hemostasis Diagnostics Market Value (US$ Mn) Analysis, by Test, 2016-2020
Table 65: South Asia & Oceania Hemostasis Diagnostics Market Value (US$ Mn) Analysis, by Test, 2021-2031
Table 66: South Asia & Oceania Hemostasis Diagnostics Market Value (US$ Mn) Opportunity Analysis, by Test, 2021-2031
Table 67: South Asia & Oceania Hemostasis Diagnostics Market Value (US$ Mn) Analysis, by Product, 2016-2020
Table 68: South Asia & Oceania Hemostasis Diagnostics Market Value (US$ Mn) Analysis, by Product, 2021-2031
Table 69: South Asia & Oceania Hemostasis Diagnostics Market Value (US$ Mn) Opportunity Analysis, by Product, 2021-2031
Table 70: South Asia & Oceania Hemostasis Diagnostics Market Value (US$ Mn) Analysis, by End User, 2016-2020
Table 71: South Asia & Oceania Hemostasis Diagnostics Market Value (US$ Mn) Analysis, by End User, 2021-2031
Table 72: South Asia & Oceania Hemostasis Diagnostics Market Value (US$ Mn) Opportunity Analysis, by End User, 2021-2031
Table 73: MEA Hemostasis Diagnostics Market Value (US$ Mn) Analysis, by Country, 2016-2020
Table 74: MEA Hemostasis Diagnostics Market Value (US$ Mn) Analysis, by Country, 2021-2031
Table 75: MEA Hemostasis Diagnostics Market Value (US$ Mn) Opportunity Analysis, by Country, 2021-2031
Table 76: MEA Hemostasis Diagnostics Market Value (US$ Mn) Analysis, by Test, 2016-2020
Table 77: MEA Hemostasis Diagnostics Market Value (US$ Mn) Analysis, by Test, 2021-2031
Table 78: MEA Hemostasis Diagnostics Market Value (US$ Mn) Opportunity Analysis, by Test, 2021-2031
Table 79: MEA Hemostasis Diagnostics Market Value (US$ Mn) Analysis, by Product, 2016-2020
Table 80: MEA Hemostasis Diagnostics Market Value (US$ Mn) Analysis, by Product, 2021-2031
Table 81: MEA Hemostasis Diagnostics Market Value (US$ Mn) Opportunity Analysis, by Product, 2021-2031
Table 82: MEA Hemostasis Diagnostics Market Value (US$ Mn) Analysis, by End User, 2016-2020
Table 83: MEA Hemostasis Diagnostics Market Value (US$ Mn) Analysis, by End User, 2021-2031
Table 84: MEA Hemostasis Diagnostics Market Value (US$ Mn) Opportunity Analysis, by End User, 2021-2031
More Insights, Lesser Cost (-50% off)
Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR
List Of Figures
Figure 1: Global Hemostasis Diagnostics Market Value (US$ Mn) Historical Analysis, 2016-2020
Figure 2: Global Hemostasis Diagnostics Market Value (US$ Mn) Forecast and Analysis, 2021-2031
Figure 3: Global Hemostasis Diagnostics Market Value Y-o-Y Growth and Forecast, 2016-2031
Figure 4: Global Hemostasis Diagnostics Market Incremental $ Opportunity, 2021-2031
Figure 5: Global Hemostasis Diagnostics Market Share and BPS Analysis by Test, 2021 & 2031
Figure 6: Global Hemostasis Diagnostics Market Y-o-Y Growth Projections by Test, 2021-2031
Figure 7: Global Hemostasis Diagnostics Market Attractiveness Analysis by Test, 2021-2031
Figure 8: Global Hemostasis Diagnostics Market Share and BPS Analysis by Product, 2021 & 2031
Figure 9: Global Hemostasis Diagnostics Market Y-o-Y Growth Projections by Product, 2021-2031
Figure 10: Global Hemostasis Diagnostics Market Attractiveness Analysis by Product, 2021-2031
Figure 11: Global Hemostasis Diagnostics Market Share and BPS Analysis by End User, 2021 & 2031
Figure 12: Global Hemostasis Diagnostics Market Y-o-Y Growth Projections by End User, 2021-2031
Figure 13: Global Hemostasis Diagnostics Market Attractiveness Analysis by End User, 2021-2031
Figure 14: Global Hemostasis Diagnostics Market Share and BPS Analysis by Region, 2021 & 2031
Figure 15: Global Hemostasis Diagnostics Market Y-o-Y Growth Projections by Region, 2021-2031
Figure 16: Global Hemostasis Diagnostics Market Attractiveness Analysis by Region, 2021-2031
Figure 17: North America Hemostasis Diagnostics Market Value (US$ Mn) Historical Analysis, 2016-2020
Figure 18: North America Hemostasis Diagnostics Market Value (US$ Mn) Forecast and Analysis, 2021-2031
Figure 19: North America Hemostasis Diagnostics Market Value Y-o-Y Growth and Forecast, 2016-2031
Figure 20: North America Hemostasis Diagnostics Market Incremental $ Opportunity, 2021-2031
Figure 21: North America Hemostasis Diagnostics Market Share Analysis by Country, 2021 & 2031
Figure 22: North America Hemostasis Diagnostics Market Y-o-Y Growth Projection by Country, 2021-2031
Figure 23: North America Hemostasis Diagnostics Market Attractiveness Analysis by Country, 2021-2031
Figure 24: North America Hemostasis Diagnostics Market Share and BPS Analysis by Test, 2021 & 2031
Figure 25: North America Hemostasis Diagnostics Market Y-o-Y Growth Projections by Test, 2021-2031
Figure 26: North America Hemostasis Diagnostics Market Attractiveness Analysis by Test, 2021-2031
Figure 27: North America Hemostasis Diagnostics Market Share and BPS Analysis by Product, 2021 & 2031
Figure 28: North America Hemostasis Diagnostics Market Y-o-Y Growth Projections by Product, 2021-2031
Figure 29: North America Hemostasis Diagnostics Market Attractiveness Analysis by Product, 2021-2031
Figure 30: North America Hemostasis Diagnostics Market Share and BPS Analysis by End User, 2021 & 2031
Figure 31: North America Hemostasis Diagnostics Market Y-o-Y Growth Projections by End User, 2021-2031
Figure 32: North America Hemostasis Diagnostics Market Attractiveness Analysis by End User, 2021-2031
Figure 33: Latin America Hemostasis Diagnostics Market Value (US$ Mn) Historical Analysis, 2016-2020
Figure 34: Latin America Hemostasis Diagnostics Market Value (US$ Mn) Forecast and Analysis, 2021-2031
Figure 35: Latin America Hemostasis Diagnostics Market Value Y-o-Y Growth and Forecast, 2016-2031
Figure 36: Latin America Hemostasis Diagnostics Market Incremental $ Opportunity, 2021-2031
Figure 37: Latin America Hemostasis Diagnostics Market Share Analysis by Country, 2021 & 2031
Figure 38: Latin America Hemostasis Diagnostics Market Y-o-Y Growth Projection by Country, 2021-2031
Figure 39: Latin America Hemostasis Diagnostics Market Attractiveness Analysis by Country, 2021-2031
Figure 40: Latin America Hemostasis Diagnostics Market Share and BPS Analysis by Test, 2021 & 2031
Figure 41: Latin America Hemostasis Diagnostics Market Y-o-Y Growth Projections by Test, 2021-2031
Figure 42: Latin America Hemostasis Diagnostics Market Attractiveness Analysis by Test, 2021-2031
Figure 43: Latin America Hemostasis Diagnostics Market Share and BPS Analysis by Product, 2021 & 2031
Figure 44: Latin America Hemostasis Diagnostics Market Y-o-Y Growth Projections by Product, 2021-2031
Figure 45: Latin America Hemostasis Diagnostics Market Attractiveness Analysis by Product, 2021-2031
Figure 46: Latin America Hemostasis Diagnostics Market Share and BPS Analysis by End User, 2021 & 2031
Figure 47: Latin America Hemostasis Diagnostics Market Y-o-Y Growth Projections by End User, 2021-2031
Figure 48: Latin America Hemostasis Diagnostics Market Attractiveness Analysis by End User, 2021-2031
Figure 49: Europe Hemostasis Diagnostics Market Value (US$ Mn) Historical Analysis, 2016-2020
Figure 50: Europe Hemostasis Diagnostics Market Value (US$ Mn) Forecast and Analysis, 2021-2031
Figure 51: Europe Hemostasis Diagnostics Market Value Y-o-Y Growth and Forecast, 2016-2031
Figure 52: Europe Hemostasis Diagnostics Market Incremental $ Opportunity, 2021-2031
Figure 53: Europe Hemostasis Diagnostics Market Share Analysis by Country, 2021 & 2031
Figure 54: Europe Hemostasis Diagnostics Market Y-o-Y Growth Projection by Country, 2021-2031
Figure 55: Europe Hemostasis Diagnostics Market Attractiveness Analysis by Country, 2021-2031
Figure 56: Europe Hemostasis Diagnostics Market Share and BPS Analysis by Test, 2021 & 2031
Figure 57: Europe Hemostasis Diagnostics Market Y-o-Y Growth Projections by Test, 2021-2031
Figure 58: Europe Hemostasis Diagnostics Market Attractiveness Analysis by Test, 2021-2031
Figure 59: Europe Hemostasis Diagnostics Market Share and BPS Analysis by Product, 2021 & 2031
Figure 60: Europe Hemostasis Diagnostics Market Y-o-Y Growth Projections by Product, 2021-2031
Figure 61: Europe Hemostasis Diagnostics Market Attractiveness Analysis by Product, 2021-2031
Figure 62: Europe Hemostasis Diagnostics Market Share and BPS Analysis by End User, 2021 & 2031
Figure 63: Europe Hemostasis Diagnostics Market Y-o-Y Growth Projections by End User, 2021-2031
Figure 64: Europe Hemostasis Diagnostics Market Attractiveness Analysis by End User, 2021-2031
Figure 65: East Asia Hemostasis Diagnostics Market Value (US$ Mn) Historical Analysis, 2016-2020
Figure 66: East Asia Hemostasis Diagnostics Market Value (US$ Mn) Forecast and Analysis, 2021-2031
Figure 67: East Asia Hemostasis Diagnostics Market Value Y-o-Y Growth and Forecast, 2016-2031
Figure 68: East Asia Hemostasis Diagnostics Market Incremental $ Opportunity, 2021-2031
Figure 69: East Asia Hemostasis Diagnostics Market Share Analysis by Country, 2021 & 2031
Figure 70: East Asia Hemostasis Diagnostics Market Y-o-Y Growth Projection by Country, 2021-2031
Figure 71: East Asia Hemostasis Diagnostics Market Attractiveness Analysis by Country, 2021-2031
Figure 72: East Asia Hemostasis Diagnostics Market Share and BPS Analysis by Test, 2021 & 2031
Figure 73: East Asia Hemostasis Diagnostics Market Y-o-Y Growth Projections by Test, 2021-2031
Figure 74: East Asia Hemostasis Diagnostics Market Attractiveness Analysis by Test, 2021-2031
Figure 75: East Asia Hemostasis Diagnostics Market Share and BPS Analysis by Product, 2021 & 2031
Figure 76: East Asia Hemostasis Diagnostics Market Y-o-Y Growth Projections by Product, 2021-2031
Figure 77: East Asia Hemostasis Diagnostics Market Attractiveness Analysis by Product, 2021-2031
Figure 78: East Asia Hemostasis Diagnostics Market Share and BPS Analysis by End User, 2021 & 2031
Figure 79: East Asia Hemostasis Diagnostics Market Y-o-Y Growth Projections by End User, 2021-2031
Figure 80: East Asia Hemostasis Diagnostics Market Attractiveness Analysis by End User, 2021-2031
Figure 81: South Asia & Oceania Hemostasis Diagnostics Market Value (US$ Mn) Historical Analysis, 2016-2020
Figure 82: South Asia & Oceania Hemostasis Diagnostics Market Value (US$ Mn) Forecast and Analysis, 2021-2031
Figure 83: South Asia & Oceania Hemostasis Diagnostics Market Value Y-o-Y Growth and Forecast, 2016-2031
Figure 84: South Asia & Oceania Hemostasis Diagnostics Market Incremental $ Opportunity, 2021-2031
Figure 85: South Asia & Oceania Hemostasis Diagnostics Market Share Analysis by Country, 2021 & 2031
Figure 86: South Asia & Oceania Hemostasis Diagnostics Market Y-o-Y Growth Projection by Country, 2021-2031
Figure 87: South Asia & Oceania Hemostasis Diagnostics Market Attractiveness Analysis by Country, 2021-2031
Figure 88: South Asia & Oceania Hemostasis Diagnostics Market Share and BPS Analysis by Test, 2021 & 2031
Figure 89: South Asia & Oceania Hemostasis Diagnostics Market Y-o-Y Growth Projections by Test, 2021-2031
Figure 90: South Asia & Oceania Hemostasis Diagnostics Market Attractiveness Analysis by Test, 2021-2031
Figure 91: South Asia & Oceania Hemostasis Diagnostics Market Share and BPS Analysis by Product, 2021 & 2031
Figure 92: South Asia & Oceania Hemostasis Diagnostics Market Y-o-Y Growth Projections by Product, 2021-2031
Figure 93: South Asia & Oceania Hemostasis Diagnostics Market Attractiveness Analysis by Product, 2021-2031
Figure 94: South Asia & Oceania Hemostasis Diagnostics Market Share and BPS Analysis by End User, 2021 & 2031
Figure 95: South Asia & Oceania Hemostasis Diagnostics Market Y-o-Y Growth Projections by End User, 2021-2031
Figure 96: South Asia & Oceania Hemostasis Diagnostics Market Attractiveness Analysis by End User, 2021-2031
Figure 97: MEA Hemostasis Diagnostics Market Value (US$ Mn) Historical Analysis, 2016-2020
Figure 98: MEA Hemostasis Diagnostics Market Value (US$ Mn) Forecast and Analysis, 2021-2031
Figure 99: MEA Hemostasis Diagnostics Market Value Y-o-Y Growth and Forecast, 2016-2031
Figure 100: MEA Hemostasis Diagnostics Market Incremental $ Opportunity, 2021-2031
Figure 101: MEA Hemostasis Diagnostics Market Share Analysis by Country, 2021 & 2031
Figure 102: MEA Hemostasis Diagnostics Market Y-o-Y Growth Projection by Country, 2021-2031
Figure 103: MEA Hemostasis Diagnostics Market Attractiveness Analysis by Country, 2021-2031
Figure 104: MEA Hemostasis Diagnostics Market Share and BPS Analysis by Test, 2021 & 2031
Figure 105: MEA Hemostasis Diagnostics Market Y-o-Y Growth Projections by Test, 2021-2031
Figure 106: MEA Hemostasis Diagnostics Market Attractiveness Analysis by Test, 2021-2031
Figure 107: MEA Hemostasis Diagnostics Market Share and BPS Analysis by Product, 2021 & 2031
Figure 108: MEA Hemostasis Diagnostics Market Y-o-Y Growth Projections by Product, 2021-2031
Figure 109: MEA Hemostasis Diagnostics Market Attractiveness Analysis by Product, 2021-2031
Figure 110: MEA Hemostasis Diagnostics Market Share and BPS Analysis by End User, 2021 & 2031
Figure 111: MEA Hemostasis Diagnostics Market Y-o-Y Growth Projections by End User, 2021-2031
Figure 112: MEA Hemostasis Diagnostics Market Attractiveness Analysis by End User, 2021-2031
Know thy Competitors
Competitive landscape highlights only certain players
Complete list available upon request
- FAQs -
How much is the global hemostasis diagnostics market currently valued at?
The global hemostasis diagnostics market is currently worth US$ 2 Bn.
What is majorly driving demand for hemostasis diagnostics?
Increased prevalence of blood clotting disorders is driving demand for hemostasis diagnostics.
Which region is expected to offer lucrative growth opportunities for vendors offering hemostasis diagnostics?
North America accounts for 50% revenue share for hemostasis diagnostics, and will remain a lucrative region for market players.
Who are the key manufacturers of hemostasis diagnostic products?
Prominent players operating in this market are Abbott Laboratories, HORIBA, Ltd., F. Hoffmann-La Roche Ltd., and Nihon Kohden Corporation.
Which segment accounts for the highest share in the market for hemostasis diagnostics?
Point-of-care testing systems hold a large revenue share of 40% in the market.
At what rate is the market predicted to register growth in Europe?
The European market is projected to expand at a CAGR of 4% during 2021 – 2031.
What will be the sales forecast for hemostasis diagnostics across 2021 to 2031?
The industry is expected to reach a value of above US$ 4 Bn by the end of 2031, with sales revenue expected to accelerate at a CAGR of around 7%.
Hemostasis Diagnostics Market